North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country and Geography

Name: North America Cancer Vaccines Market
SKU: Pharmaceuticals
Rating: 4.8 (16 reviews)

Market Introduction

This research report provides insights into the global Cancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines

Get more information on this report :

Market Overview and Dynamics

The North America cancer vaccines market is expected to reach US$ 6,623.6 million by 2027 from US$ 1,875.7 million in 2019. The market is anticipated to grow with a CAGR of 17.5% from 2020 to 2027. Factors driving the market growth include increase in prevalence of cancer worldwide, and initiatives taken by global health research organizations and key players for cancer vaccines.COVID19 has impacted the market heavily due to disruption in supply chain and lockdown conditions. However, the challenges in cancer vaccines industry like higher cost of cancer vaccines restrains the growth of the market.

Key Market Segments

In terms of technology, the recombinant cancer vaccines segment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019 and also is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of end user, the pediatrics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.

Major Sources and Companies Listed

The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the North America cancer vaccines market included in the report.

Reasons to buy the report

To understand the North America cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for the North America cancer vaccines market
Efficiently plan M&A and partnership deals in the North America cancer vaccines market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the North America cancer vaccines market
Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

North America Cancer vaccines Market Segmentation

By Technology

Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen Cancer Vaccines
Whole Cell Cancer Vaccines
Viral Vector Cancer Vaccines

North America Cancer Vaccines Market – By Type

Preventive Cancer Vaccines
Therapeutic Cancer Vaccine

North America Cancer Vaccines Market – By Indication

Cervical Cancer
Prostate Cancer
Other Indications

North America Cancer Vaccines Market– By End Use

Pediatrics
Adults

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Cancer Vaccines Market – By Technology

1.3.2 North America Cancer Vaccines Market – By Type

1.3.3 North America Cancer Vaccines Market – By Indication

1.3.4 North America Cancer Vaccines Market– By End Use

1.3.5 North America Cancer Vaccines Market– By Region

2. Cancer Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Cancer Vaccines – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. North America Cancer Vaccines Market – Industry Dynamics

5.1 Key Drivers

5.1.1 Increase in Prevalence of Cancer Worldwide

5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines

5.2 Key Market Restraints

5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer

5.2.2 Higher Cost of Cancer Vaccines

5.3 Key Market Opportunities

5.3.1 Increasing Government support in Emerged Countries

5.4 Future Trends

5.4.1 Growing Research and Development Activities

5.5 Impact analysis

6. Cancer Vaccines Market – Regional Analysis

6.1 North America Cancer Vaccines Market Revenue Forecast And Analysis

7. North America Cancer Vaccines Market Analysis – By Technology

7.1 Overview

7.2 Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%)

7.3 Dendritic Cells Cancer Vaccine

7.3.1 Overview

7.3.2 Dendritic Cells Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Recombinant Cancer Vaccines

7.5.1 Overview

7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Antigen Cancer Vaccines

7.6.1 Overview

7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7 Whole Cell Cancer Vaccines

7.7.1 Overview

7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.8 Viral Vector Cancer Vaccines

7.8.1 Overview

7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8. Cancer Vaccines Market Analysis – By Type

8.1 Overview

8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)

8.3 Preventive Cancer Vaccines

8.3.1 Overview

8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Therapeutic Cancer Vaccines

8.4.1 Overview

8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9. Cancer Vaccines Market Analysis – By Indication

9.1 Overview

9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)

9.3 Cervical Cancer

9.3.1 Overview

9.3.2 Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Prostate Cancer

9.4.1 Overview

9.4.2 Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Other Indications

9.5.1 Overview

9.5.2 Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

10. Cancer Vaccines Market Analysis – By End Use

10.1 Overview

10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)

10.3 Pediatrics

10.3.1 Overview

10.3.2 Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

10.4 Adults

10.4.1 Overview

10.4.2 Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11. Cancer Vaccines Market – Geographic Analysis

11.1 North America: Cancer Vaccines Market

11.1.1 Overview

11.1.2 North America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.3 North America: Cancer Vaccines Market, by Technology, 2018–2027 (USD Million)

11.1.4 North America: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.5 North America: Cancer Vaccines Market, by Indication, 2018–2027 (USD Million)

11.1.6 North America: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.1.7 North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)

11.1.8 US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1 US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2 US: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.8.3 US: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.1.8.4 US: Cancer Vaccines Market, by Technology2018–2027 (USD Million)

11.1.8.5 US: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.1.9 Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1 Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2 Canada: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.9.3 Canada: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.1.9.4 Canada: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.1.9.5 Canada: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.1.10 Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.10.3 Mexico: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.1.10.4 Mexico: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.1.10.5 Mexico: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Cancer Vaccines Market – Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 CSL Limited

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 ADURO BIOTECH INC.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Astellas Pharma Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Bristol-Myers Squibb Company

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 GlaxoSmithKline plc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Dendreon

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 AstraZeneca

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Merck & Co., Inc.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Sanofi (Sanofi Pasteur)

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 OSE Immunotherapeutics

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 Glossary of Terms

LIST OF TABLES

Table 1. North America Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 2. North America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3. North America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 4. North America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5. Estimated Number of New Cancer Cases and Deaths, US, 2020

Table 6. US Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7. US Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 8. US Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 9. US Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 13. Canada Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Incidence, Mortality and Prevalence by cancer site in 2018

Table 15. Mexico Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16. Mexico Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 17. Mexico Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 18. Mexico Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19. Organic Developments Done By Companies

Table 20. Inorganic Developments Done By Companies

Table 21. Glossary of Terms, Cancer Vaccines Market

LIST OF FIGURES

Figure 1. Cancer Vaccines Market Segmentation

Figure 2. Cancer Vaccines Segmentation – By Region

Figure 3. North America Cancer Vaccines Market Overview

Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019

Figure 5. Cancer Vaccines Market in US to Show Remarkable Growth During Forecast Period

Figure 7. North America PEST Analysis

Figure 8. Cancer Statistics, 2020

Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints

Figure 10. North America Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027

Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)

Figure 12. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)

Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)

Figure 21. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)

Figure 25. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27. North America: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 28. North America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 29. North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)

Figure 30. US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 31. Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. Impact of COVID-19 Pandemic in North American Country Markets

Figure 34. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - North America Cancer Vaccines Market

To understand the North America cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for the North America cancer vaccines market
Efficiently plan M&A and partnership deals in the North America cancer vaccines market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the North America cancer vaccines market
Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample